Search

Author(s): Marco Massari 1, Stefania Spila Alegiani 1, Cristina Morciano 1,*, Matteo Spuri 2, Pasquale Marchione 3, Patrizia Felicetti 3, Valeria Belleudi 4, Francesca Romana Poggi 4, Marco Lazzeretti 5, [...], Background Myocarditis and pericarditis following the Coronavirus Disease 2019 (COVID-19) mRNA vaccines administration have been reported, but their frequency is still uncertain in the younger population. This study investigated the association between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA vaccines, BNT162b2, and mRNA-1273 and myocarditis/pericarditis in the population of vaccinated persons aged 12 to 39 years in Italy. Methods and findings We conducted a self-controlled case series study (SCCS) using national data on COVID-19 vaccination linked to emergency care/hospital discharge databases. The outcome was the first diagnosis of myocarditis/pericarditis between 27 December 2020 and 30 September 2021. Exposure risk period (0 to 21 days from the vaccination day, subdivided in 3 equal intervals) for first and second dose was compared with baseline period. The SCCS model, adapted to event-dependent exposures, was fitted using unbiased estimating equations to estimate relative incidences (RIs) and excess of cases (EC) per 100,000 vaccinated by dose, age, sex, and vaccine product. Calendar period was included as time-varying confounder in the model. During the study period 2,861,809 persons aged 12 to 39 years received mRNA vaccines (2,405,759 BNT162b2; 456,050 mRNA-1273); 441 participants developed myocarditis/pericarditis (346 BNT162b2; 95 mRNA-1273). Within the 21-day risk interval, 114 myocarditis/pericarditis events occurred, the RI was 1.99 (1.30 to 3.05) after second dose of BNT162b2 and 2.22 (1.00 to 4.91) and 2.63 (1.21 to 5.71) after first and second dose of mRNA-1273. During the [0 to 7) days risk period, an increased risk of myocarditis/pericarditis was observed after first dose of mRNA-1273, with RI of 6.55 (2.73 to 15.72), and after second dose of BNT162b2 and mRNA-1273, with RIs of 3.39 (2.02 to 5.68) and 7.59 (3.26 to 17.65). The number of EC for second dose of mRNA-1273 was 5.5 per 100,000 vaccinated (3.0 to 7.9). The highest risk was observed in males, at [0 to 7) days after first and second dose of mRNA-1273 with RI of 12.28 (4.09 to 36.83) and RI of 11.91 (3.88 to 36.53); the number of EC after the second dose of mRNA-1273 was 8.8 (4.9 to 12.9). Among those aged 12 to 17 years, the RI was of 5.74 (1.52 to 21.72) after second dose of BNT162b2; for this age group, the number of events was insufficient for estimating RIs after mRNA-1273. Among those aged 18 to 29 years, the RIs were 7.58 (2.62 to 21.94) after first dose of mRNA-1273 and 4.02 (1.81 to 8.91) and 9.58 (3.32 to 27.58) after second dose of BNT162b2 and mRNA-1273; the numbers of EC were 3.4 (1.1 to 6.0) and 8.6 (4.4 to 12.6) after first and second dose of mRNA-1273. The main study limitations were that the outcome was not validated through review of clinical records, and there was an absence of information on the length of hospitalization and, thus, the severity of the outcome. Conclusions This population-based study of about 3 millions of residents in Italy suggested that mRNA vaccines were associated with myocarditis/pericarditis in the population younger than 40 years. According to our results, increased risk of myocarditis/pericarditis was associated with the second dose of BNT162b2 and both doses of mRNA-1273. The highest risks were observed in males of 12 to 39 years and in males and females 18 to 29 years vaccinated with mRNA-1273. The public health implication of these findings should be considered in the light of the proven mRNA vaccine effectiveness in preventing serious COVID-19 disease and death.

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.icarus.2007.04.023 Byline: Rosario Brunetto (a)(b), Ted L. Roush (c), Anna Cinzia Marra (a), Vincenzo Orofino (a) Keywords: Asteroids; surfaces; Centaurs; Spectroscopy; Experimental techniques Abstract: We perform an optical characterization of UV laser ablated silicates (olivine, pyroxene), starting from their reflectance spectra in the 0.3-2.5 [mu]m spectral range. The goal is to provide useful tools to model space weathering effects on surfaces of asteroids and TNOs (trans-neptunian objects). We determine that the reddening and darkening spectral trend is compatible with the Hapke's space weathering model, using the optical constants of metallic iron in a silicate matrix. This result is supported by new magnetic susceptibility measurements on laser ablated orthopyroxene. We also investigate the potential contribution of formation of amorphous silicates in the process. Applying our results to silicate-rich surfaces in the Solar System, we investigate the possibility of a weathered olivine component on the surface of Centaur 5145 Pholus. Inclusion of this component slightly decreases the amount of complex organics and water ice from those previously estimated. Thus, the current Pholus spectrum is consistent with the presence of either unweathered or weathered olivine, or potentially both materials. Author Affiliation: (a) Dipartimento di Fisica, Universita di Lecce, via Arnesano, I-73100 Lecce, Italy (b) INAF-Osservatorio Astrofisico di Catania, via S. Sofia 78, I-95123 Catania, Italy (c) NASA Ames Research Center, MS 245-3, Moffett Field, CA 94035-1000, USA Article History: Received 13 November 2006; Revised 28 February 2007